Systems and education to improve cervical cancer screening and follow-up

Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)

['FUNDING_R01'] · BOSTON MEDICAL CENTER · NIH-11322706

This project adapts a clinician education and quality-improvement approach to help people in underserved Black, Hispanic, low-income, and Native Hawaiian/Pacific Islander communities get regular cervical cancer screening and complete follow-up.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorBOSTON MEDICAL CENTER (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-11322706 on ClinicalTrials.gov

What this research studies

This project adapts a proven clinician education and quality-improvement program to help clinics increase cervical cancer screening and ensure follow-up after abnormal results. The team will tailor the approach for three underserved communities—urban Black and Haitian patients in Boston, Hispanic immigrants in Florida, and Native Hawaiian/Pacific Islander patients in Hawaii—working directly with clinics there. Clinicians will complete Performance Improvement Continuing Medical Education modules and implement practice-level quality improvements while researchers track screening and follow-up rates. Researchers will compare screening and follow-up before and after the intervention to see if more people are reached and kept in care.

Who could benefit from this research

Good fit: Ideal candidates are people served by participating clinics who are overdue for cervical screening or who live in the targeted communities in Boston, Florida, or Hawaii.

Not a fit: People who already receive regular screening, who do not use the participating clinics, or who live outside the study locations are unlikely to benefit directly.

Why it matters

Potential benefit: If successful, more people in underserved communities could receive regular cervical cancer screening and timely follow-up, reducing cancer risk and narrowing racial and ethnic disparities.

How similar studies have performed: The team previously used this approach to increase HPV vaccination by over 10 percentage points with gains lasting more than four years, suggesting the method can work in related prevention efforts.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.